Hints and tips:
...’s UCSF Memory and Aging Center, which played a role in the Leqembi trial....
...In the wake of the controversy over the FDA approval of Biogen’s aducanumab, the US Centers for Medicare and Medicaid Services said only patients taking part in a clinical trial would benefit from reimbursement...
...More than four in 10 American adults are clinically obese, according to the Centers for Disease Control and Prevention, which estimated the annual medical costs of the condition at almost $173bn in 2019....
...It added that all available safety information indicated the therapy was not associated with “an increased risk of death overall or from any specific cause”....
...“This would give us a foot in the door for treatments because ultimately down the road its going to take combination therapy to have a voilà kind of effect,” he said....
...Life sciences companies seek to engineer and manufacture a new generation of more targeted gene and cell therapies to treat disease, as well as new types of vaccines, nutritional and agricultural products...
...Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement: “Because data show these treatments are highly unlikely to be active against the Omicron variant, which...
...The unusual price reduction comes as the US Centers for Medicare and Medicaid Services is considering whether to cover the drug within Medicare, the programme for senior citizens....
...In the Philippines, community health centres paused sexual and reproductive health programmes to focus on Covid, according to the University of the Philippines Center for Women’s and Gender Studies....
...Helen Boucher, chief of the division of geographic medicine and infectious diseases at Tufts Medical Center, said: “There’s a cry for whatever therapy we can get.”...
...It then obtained approval for the preventive use of Truvada and Descovy, a newer drug, by using data from Centers for Disease Control, a government agency, HHS said....
...But they were determined to explore every type of therapy, and eventually “we found a way to reach him through music”....
...Tiffany Farchione, acting director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research, said there had been a “longstanding need for additional effective treatments...
...The company is working with leading oncologists and immunologists including Hans-Peter Kiem, the director of the stem cell and gene therapy program at the Fred Hutchinson Cancer Research Center, and Dan...
...But many people are more likely to be hit by the creeping steady rise of popular drugs and high price tags for innovative treatments, such as new therapies for cancer....
...Last financial year IGC made $2.2m in sales (zero from its cannabis therapies business), and lost $1.8m. It therefore trades at a price to sales of 134....
...They can therefore be treated with hormone therapy alone, which is far milder....
...New research sheds light on how melatonin promotes sleep and could lead to new sleep therapies....
...Since 2003, Pepfar has provided 13.3m HIV-infected people with antiretroviral therapy and provided care for more than 6.4m orphans and vulnerable children....
...A version of this article was first published by the Nikkei Asian Review on May 15. ©2018 Nikkei Inc. All rights reserved....
...of The Carter Center and supporter of a new neglected tropical diseases fund unveiled in the Gulf....
...What is the strongest argument to vote for you rather than the other DG candidates? I have been a change-maker my entire career and one thing WHO needs now is that....
...“Payers have their antenna up and . . . they will be aggressive in containing utilisation,” says Dr Peter Bach, a pricing expert at Memorial Sloan Kettering Cancer Center....
...Cell therapy advocates point out that Dendreon’s Provenge treatment for prostate cancer was less effective than CAR-T therapies and say lessons have been learned from Dendreon’s failure....
...Mr Freeman’s vision will be set out in an official report later this year which is expected to propose mechanisms for getting the most promising new therapies to patients faster and affordably....
International Edition